Skip to content

Comparison of the Time to Obtain Results from Two Blood Clotting Tests Used During Surgery

Comparison of Time for Diagnosing Intraoperative Coagulopathies: Point-of-care Viscoelastic Tests (POCT) vs Standard Central Laboratory Tests (SCLT)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0012267
Enrollment
98
Registered
2026-07-13
Start date
2026-01-18
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Konkuk University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 19 years or older 2. Patients who are likely to undergo standard central laboratory coagulation testing (SCLT) or point-of-care viscoelastic testing (POCT) during surgery 3. Patients who provide written informed consent to participate in this study

Exclusion criteria

Exclusion criteria: 1. Pregnant women (because coagulation characteristics differ from those of the general population) 2. Patients who do not provide informed consent to participate in this study 3. Patients whom the investigators consider unsuitable for participation in the study

Design outcomes

Primary

MeasureTime frame
Diagnostic turnaround time of point-of-care viscoelastic testing (POCT) and standard central laboratory testing (SCLT), defined as the time from blood sample collection to availability of test results.

Secondary

MeasureTime frame
Comparison of the diagnostic results between point-of-care viscoelastic testing (POCT) and standard central laboratory testing (SCLT);Comparison of the utilization rates of POCT and SCLT for the diagnosis of intraoperative coagulopathy;Comparison of the proportion of patients diagnosed with coagulopathy using POCT and SCLT;Agreement between POCT and SCLT in the diagnosis of intraoperative coagulopathy;Comparison of the time to treatment initiation, defined as the interval from prescription (ordering) of blood products or coagulation factor concentrates after review of the test results to the start of transfusion or administration;Comparison of the time to treatment completion, defined as the interval until completion of blood product transfusion;Comparison of blood product utilization according to the diagnostic results

Countries

Korea, Republic of

Contacts

Public Contacthyewon lee

Konkuk University Medical Center

hwon.kku@gmail.com+82-2-2030-5445

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jul 23, 2026